Navigare Ventures

Investment Focus

Investment Stages

Geographic Focus

Nordics
Europe

Inferred Thesis

Auto-generated from public data. Not the firm's stated position.

Navigare Ventures appears to focus on early-stage deep technology companies in Northern Europe, with recent portfolio activity suggesting a concentration in biotech applications and advanced materials or semiconductor hardware. The disclosed check size of €1.5M–€3.0M and seed to Series A stage preference indicate positioning as a specialized early-stage investor backing capital-intensive, science-driven ventures.

Generated 14 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].

How to Pitch Navigare Ventures

No Stated Policy
Navigare Ventures hasn't published an outreach policy. A short, specific cold email is the safest default.
Source

Portfolio Highlights

Elypta - liquid biopsy
EnginZyme - biomanufacturing
SweGaN - GaN semiconductors

Focus and check size from the firm's website. Website reachable as of Sept 2026.

Ready to Reach Navigare Ventures?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.